The economic burden of depression and the cost-effectiveness of treatment

International Journal of Methods in Psychiatric Research

Volumn 12, Issue 1, 2003, Pages 22-33

  Wang, Philip S ^a   Simon, Gregory ^b   Kessler, Ronald C ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cost effectiveness; Depression; Economic burden; Treatment

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CONSUMER; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DEPRESSION; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH PROGRAM; HUMAN; JOB PERFORMANCE; MEDICAL LITERATURE; MEDICAL RESEARCH; MODEL; PRIMARY MEDICAL CARE; PRODUCTIVITY; STANDARD; SYMPTOMATOLOGY; TREATMENT OUTCOME; UNITED STATES;

COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER; HUMANS; TREATMENT OUTCOME;

EID: 0038316443     PISSN: 10498931     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpr.139     Document Type: Article

References (85)

1. Agency for Health Care Policy and Research. Depression in Primary Care, Vol. 2. Treatment of Major Depression. Rockville MD: US Department of Health and Human Services, 1993.
2. Agosti V, Stewart JW, Quitkin FM. Life satisfaction and psychosocial functioning in chronic depression: effect of acute treatment with antidepressants. J Affect Disord 1991; 23: 35-41.
3. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder. 2 edn. Washington DC: American Psychiatric Association, 2000.
4. Barge-Schaapveld DQ, Nicolson NA, Van der Hoop RG, et al. Changes in daily life experience associated with clinical improvement in depression. J Affect Disord 1995; 34: 139-54.
5. Bergner M, Bobbitt RA, Carter WB, et al. The Sickness Impact Profile: development and final revisions of a health status measure. Med Care 1981; 19: 787-805.
6. Berndt ER, Finkelstein SN, Greenberg PE, et al. Workplace performance effects from chronic depression and its treatment. J Health Econ 1998; 17: 511-35.
7. Broadhead WE, Blazer DG, George LK, et al. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA 1990; 264: 2524-8.
8. Caplan RD, Abbey A, Abramis DJ, et al. Tranquilizer Use and Well-being: A Longitudinal Study of Social and Psychological Effects. Ann Arbor: Institute for Social Research, 1984.
9. Centers for Disease Control and Prevention. Health-related quality of life and activity limitation-eight states, 1995. MMWR Mor Mortal Wkly Rep 1998; 47: 134-40.
10. Coryell W, Scheftner W, Keller M, et al. The enduring psychosocial consequences of mania and depression. Am J Psychiatry 1993; 150: 720-7.
11. Coulehan JL, Schulberg HC, Block MR, et al. Treating depressed primary care patients improves their physical, mental and social functioning. Arch Intern Med 1997; 157: 1113-20.
12. Crofton C, Lubalin JS, Darby C. Consumer Assessment of Health Plans Study (CAHPS). Med Care 1999; 37 (3, suppl.): MS1-9.
13. Eaton WW, Anthony JC, Mandel W, et al. Occupations and the prevalence of major depressive disorder. J Occup Med 1990; 32: 1079-87.
14. Finkelstein SN, Berndt ER, Greenberg PE, et al. Improvement in subjective work performance after treatment of chronic depression: some preliminary results. Chronic Depression Study Group Psychopharmacol Bull 1996; 32: 33-40.
15. Friedman RA, Markowitz JC, Parides M, et al. Acute response of social functioning in dysthymic patients with desipramine. J Affect Disord 1995; 34: 85-8.
16. Greenberg PE, Kessler RC, Nells TL, et al. Depression in the workplace: an economic perspective. In Feighner JP, Boyer WF (eds) Selective Serotonin Re-Uptake Inhibitors: Advances in Basic Research and Clinical Practice. New York: John Wiley & Sons, 1996, 327-63.
17. Greenberg PE, Stiglin LE, Finkelstein SN, et al. The economic burden of depression in 1990. J Clin Psychiatry 1993; 54: 405-18.
18. Harwood HJ, Napolitano DM, Kristiansen P, et al. Economic Costs to Society of Alcohol and Drug Abuse and Mental Illness, 1980. Research Triangle Park NC: Research Triangle Institute, 1984.
19. Hays RD, Wells KB, Sherbourne CD, et al. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry 1995; 52: 11-19.
20. Hunkeler EM, Meresman JF, Hargreaves WA, et al. Efficacy of nurse telehealth care and peer support in augmenting treatment of depression in primary care. Arch Fam Med 2000; 9: 700-8.
21. Jacob M, Frank E, Kupfer DJ, et al. Recurrent depression: an assessment of family burden and family attitudes. J Clin Psychiatry 1987; 48: 395-400.
22. Jarvinen D. Cost of Illness Studies: An Annotated Bibliography. University of California. San Francisco: Institute for Health and Aging, 1988.
23. Katon W, Robinson P, Von Korff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry 1996; 53: 924-32.
24. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA 1995; 273: 1026-31.
25. Katon W, Von Korff M, Lin E, et al. Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry 1999; 56: 1109-15.
26. Katzelnick DJ Simon GE, Pearson SD, et al. Randomized trial of a depression management program in high utilizers of medical care. Arch Fam Med 2000; 9: 345-51.
27. Keller MB, Klerman GL, Lavori PW, et al. Treatment received by depressed patients. JAMA 1982; 248: 1848-55.
28. Keller MB, Lavori PW, Klerman GL, et al. Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients. Arch Gen Psychiatry 1986; 43: 458-66.
29. Kessler RC, Barber C, Birnbaum HG, et al. Depression in the workplace: effects on short-term work disability. Health Aff 1999; 18: 163-71.
30. Kessler RC, Berglund PA, Bruce ML, et al. The prevalence and correlates of untreated serious mental illness. Health Serv Res 2001; 36: 987-1007.
31. Kessler RC, Foster CL, Saunders WB, et al. Social consequences of psychiatric disorders, I: Educational attainment. Am J Psychiatry 1995; 152: 1026-32.
32. Kessler RC, Frank RG. The impact of psychiatric disorders on work loss days. Psychol Med 1997a; 27: 861-73.
33. Kessler RC, Greenberg PE, Mickelson KD, et al. The effects of chronic medical conditions on work loss and work cutback. J Occup Environ Med 2001; 43: 218-25.
34. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8-19.
35. Klerman GL, Weissman MM. The course, morbidity and costs of depression. Arch Gen Psychiatry 1992; 49: 831-4.
36. Klinkman MS. Competing demands in psychosocial care: a model for the identification and treatment of depressive disorders in primary care. Gen Hosp Psychiatry 1997; 19: 98-111.
37. Kocsis JH, Frances AJ, Voss C, et al. Imipramine and social-vocational adjustment in chronic depression. Am J Psychiatry 1988; 145: 997-9.
38. Kocsis JH, Zisook S, Davidson J, et al. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. Am J Psychiatry 1997; 154: 390-5.
39. Kouzis AC, Eaton WW. Emotional disability days: Prevalence and predictors. Am J Public Health 1994; 84: 1304-7.
40. Lave JR, Frank RG, Schulberg HC, et al. Cost-effectiveness of treatments for major depression in primary care practice. Arch Gen Psychiatry 1998; 55: 645-51.
41. Leader JB, Klein DN. Social adjustment in dysthymia, double depression and episodic major depression. J Affect Disord 1996; 37: 91-101.
42. Martin JK, Blum TC, Beach SRH, et al. Subclinical depression and performance at work. Soc Psychiatry Psychiatr Epidemiol 1996; 31: 3-9.
43. Mauskopf JA, Simeon GP, Miles MA, et al. Functional status in depressed patients: the relationship to disease severity and disease resolution. J Clin Psychiatry 1996; 57: 588-92.
44. McHorney CA, Ware JE Jr, Rachel Lu JF, et al. The MOS 36-Item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994; 32: 40-66.
45. Mintz J, Mintz LI, Arruda MJ, et al. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 1992; 49: 761-8.
46. Morgado A, Smith M, Lecrubier Y, et al. Depressed subjects unwittingly over-report poor social adjustment which they reappraise when recovered. J Nerv Ment Dis 1991; 179: 614-19.
47. Murray CJL, Lopez AD. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard University Press, 1996.
48. Mynors-Wallis LM, Gath DH, Lloyd-Thomas AR, et al. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ 1995; 310: 441-5.
49. Narrow WE, Rae DS, Robins LN, et al. Revised prevalence of mental disorders in the United States using a clinical significance criterion to reconcile 2 surveys' estimates. Arch Gen Psychiatry 2002; 59: 115-23.
50. National Committee for Quality Assurance: HEDIS 3.0: Narrative: What's In It and Why it Matters. Washington DC: National Committee for Quality Assurance, 1997.
51. Olfson M, Marcus SC, Druss B, et al. National trends in outpatient treatment of depression. JAMA 2002; 287: 203-9.
52. Ormel J, Koeter MW, Van den Brink W, et al. Recognition, management, and course of anxiety and depression in general practice. Arch Gen Psychiatry 1991; 48: 700-6.
53. Ormel J, Van den Brink W, Koeter MW, et al. Recognition, management, and outcome of psychological disorders in primary care: a naturalistic follow-up study. Psychol Med 1990; 20: 909-23.
54. Ormel J, Von Korff M, Ustun TB, et al. Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care. JAMA 1994; 272: 1741-8.
55. Ormel J, Von Korff M, Van Den Brink W, et al. Depression, anxiety, and social disability show synchrony of change in primary care patients. Am J Public Health 1993; 83: 385-90.
56. Regier, DA, Narrow, WE, Rae DS, et al. The de facto US mental and addictive disorders service system. Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry 1993; 50: 85-94.
57. Revicki DA, Irwin D, Reblando J, et al. The accuracy of self-reported disability days. Med Care 1994; 32: 401-4.
58. Rice DP, Kelman S, Miller LS, et al. The Economic Costs of Alcohol and Drug Abuse and Mental Illness: 1985. Rockville MD: Alcohol, Drug Abuse, and Mental Health Administration, 1990.
59. Rohde P, Lewinsohn PM, Seeley JR. Are people changed by the experience of having an episode of depression? A further test of the scar hypotheses. J Abnorm Psychol 1990; 99: 264-71.
60. Rost K, Nutting PA, Smith J, et al. Designing and implementing a primary care intervention trial to improve the quality and outcome of care for major depression. Gen Hosp Psychiatry 2000; 22: 66-77.
61. Sartorius N, Ustun TB. Mental Illness in Primary Care: An International Study. New York: John Wiley & Sons, 1995.
62. Schoenbaum M, Unutzer J, Sherbourne C, et al. Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial. JAMA 2001; 286: 1325-30.
63. Schulberg HC, Block MR, Madonia MJ, et al. Treating major depression in primary care practice. Eight-month clinical outcomes. Arch Gen Psychiatry 1996; 53: 913-19.
64. Simon GE, Katon W, Rutter C, et al. Impact of improved depression treatment in primary care on daily functioning and disability. Psychol Med 1998a; 28: 693-701.
65. Simon GE, Karon W, Rutter C, et al. Impact of improved depression treatment in primary care on daily functioning and disability. Psychol Med 1998b; 28: 693-701.
66. Simon GE, Katon WJ, Von Korff M, et al. Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. Am J Psychiatry 2001a; 158: 1638-44
67. Simon GE, Katzelnick DJ. Depression, use of medical services, and cost-offset effects. J Psychosom Res 1997; 42: 333-44
68. Simon GE, Manning WG, Katzelnick DJ, et al. Cost-effectiveness of systematic depression treatment for high utilizers of general medical care. Arch Gen Psychiatry 2001b; 58: 181-7.
69. Simon GE, VonKorff M, Rutter C, et al. Randomized trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. BMJ 2000; 320: 550-4.
70. Stoudemire A, Frank R, Hedemark N, et al. The economic burden of depression. Gen Hosp Psychiatry 1986; 8: 387-94.
71. Tollefson GD, Souetre E, Thomander L, et al. Comorbid anxious signs and symptoms in major depression: Impact on functional work capacity and comparative treatment outcomes. Int Clin Psychopharmacol 1993; 8: 281-93.
72. Tweed DL. Depression-related impairment: estimating concurrent and lingering effects. Psychol Med 1993; 23: 373-86.
73. Von Korff M, Katon W, Bush T, et al. Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosom Med 1998; 60: 143-9.
74. Von Korff M, Ormel J, Katon W, et al. Disability and depression among high utilizers of health care. A longitudinal analysis. Arch Gen Psychiatry 1992; 49: 91-100.
75. Wang PS, Berglund P, Kessler RC. Recent care of common mental disorders in the United States: prevalence and conformance with evidence-based recommendations. J Gen Intern Med 2000; 15: 284-92.
76. Wang PS, Demler O, Kessler RC. The adequacy of treatment for serious mental illness in the United States. Am J Pub Health 2002; 92: 92-8.
77. Weissman MM, Prusoff BA, Thompson WD, et al. Social adjustment by self-report in a community sample and in psychiatric outpatients. J Nerv Ment Dis 1978; 166: 317-26.
78. Wells KB, Katon W, Rogers B, et al. Use of minor tranquilizers and antidepressant medications by depressed outpatients: results from the medical outcomes study. Am J Psychiatry 1994; 151: 694-700
79. Wells KB, Sherbourne C, Schoenbaum M, et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA 2000; 283: 212-20.
80. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: Results from the Medical Outcomes Study. JAMA 1989; 262: 914-19.
81. Wells KB, Sturm R, Sherbourne CD, et al. Caring for Depression. Cambridge MA: Harvard University Press, 1996.
82. Williams JW Jr. Competing demands: does care for depression fit in primary care? J Gen Intern Med 1998; 13: 137-9.
83. Woods SW, Baker CB. Cost-effectiveness of the newer generation of antidepressants. In: Davis KL, Coyle JT, Nemeroff C (eds) Neuropsychopharmacology: The Fifth Generation of Progress. Philadelphia PA: American College of Neuropsychopharmacology 2002: 1119-37.
84. Young AS, Klap R, Scherbourne CD, et al. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001; 58: 55-61.
85. Zeiss AM, Lewinsohn PM. Enduring deficits after remission of depression: a test of the scar hypothesis. Behav Res Ther 1988; 26: 151-8.